Glaukos CFO Alex Thurman Sells $1.6 Million in Stock. What Should Investors Do Now?
Disposition represented 19% of insider's equity holdings under pre-established Rule 10b5-1 trading plan. Thurman retains 43,681 shares worth approximately $6.77 million.
Overview
Alex R. Thurman, SVP & Chief Financial Officer of Glaukos Corporation (NYSE:GKOS), sold 10,000 shares of common stock on July 9, 2026, according to an SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($155.00); post-transaction value based on July 9 market close ($155.07).
Details
Glaukos Corporation is a specialized ophthalmic medical technology company with a $9 billion market capitalization, generating $551 million in trailing-12-month revenue while investing substantially in research and development to expand its product pipeline. The company maintains a competitive advantage through its proprietary micro-bypass stent technology and established relationships with ophthalmologists, positioning it as a leader in the minimally invasive glaucoma surgery market. With 995 employees and headquarters in Aliso Viejo, California, Glaukos is focused on addressing significant unmet medical needs in ophthalmic care through both device innovation and pharmaceutical development.
Source
Originally published at www.fool.com.